Results 1 to 10 of about 1,017 (102)

Clinical Utility of the aMAP Score for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B [PDF]

Diagnostics
This study aimed to evaluate the efficacy of the aMAP score and compare it with other risk scores for predicting hepatocellular carcinoma (HCC) development in Thai patients with chronic hepatitis B (CHB).
Supakorn Chaiwiriyawong, Suraphon Assawasuwannakit, Poorikorn Feuangwattana, Pimsiri Sripongpun, Naichaya Chamroonkul, Teerha Piratvisuth, Apichat Kaewdech   +6 more
doaj   +6 more sources

aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure [PDF]

International Journal of General Medicine, 2022
Yunqing Sun,* Zhuohong Li,* Guichan Liao, Muye Xia, Xuwen Xu, Shaohang Cai, Jie Peng Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, People’s Republic of China*These authors ...
Sun Y, Li Z, Liao G, Xia M, Xu X, Cai S, Peng J   +6 more
doaj   +5 more sources

Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify [PDF]

British Journal of Cancer, 2022
Abstract Background and aims The aMAP score is a model that predicts risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis. Its performance in a ‘real world’ surveillance setting has not yet been ascertained. Patients and methods We had access
Philip J Johnson, Hamish Innes, David M Hughes   +2 more
exaly   +5 more sources

The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study [PDF]

Journal of Cancer, 2023
Background: A less effective nomogram for patients with intermediate-stage hepatocellular carcinoma (HCC) to predict overall survival (OS) is available. This study aimed to investigate the role of age-male-albumin-bilirubin-platelet (aMAP) scores in the prognosis of patients with intermediate-stage HCC and develop an aMAP score-based nomogram to ...
Linbin Lu, Qin Lin, Lu Linbin
exaly   +4 more sources

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy [PDF]

Frontiers in Medicine, 2021
Background and Aim: A prediction model of hepatocellular carcinoma (HCC) risk in patients with chronic liver diseases, based on age, male sex, albumin-bilirubin, and platelets (aMAP), has been previously reported. We validated the aMAP score and compared
Honglian Gui, Yan Huang, Gangde Zhao, Lichang Chen, Wei Cai, Hui Wang, Qing Guo, Qing Xie   +7 more
doaj   +5 more sources

Association between the aMAP risk score and mortality in the MASLD/MetALD/ALD patient population: a cohort study [PDF]

Frontiers in Medicine
BackgroundThe age–male–ALBI–platelets (aMAP) risk score, an emerging non-invasive marker for liver fibrosis and hepatocellular carcinoma, has shown potential in risk stratification.
Peng-yang Li, Yuan-xin Mo, Rui-biao Fu, Jian Song, Shao-lei Kuang, Yuan-quan Zhao, Wei Jiang, Xiao-feng Dong   +7 more
doaj   +3 more sources

The aMAP score combined with plasma cfDNA methylation testing for risk stratification in hepatitis population: a case-control study [PDF]

Scientific Reports
Effective surveillance of the hepatitis populations reduces liver cancer incidence and improves prognosis. This study aimed to develop an easy and non-invasive risk assessment model for this population.
Dianyan Chen, Ka Zhang, Tingyong Lv, Xuezhong Jian, Jin Zhang, Yinghong An, Dingyao Ren, Fei Long, Sandu Liu   +8 more
doaj   +3 more sources

Assessing the Predictive Accuracy of the aMAP Risk Score for Hepatocellular Carcinoma (HCC): Diagnostic Test Accuracy and Meta-analysis [PDF]

Journal of Clinical and Experimental Hepatology
We aimed to perform a meta-analysis with the intention of evaluating the reliability and test accuracy of the aMAP risk score in the identification of HCC.A systematic search was performed in PubMed, Scopus, Cochrane, Embase, and Web of Science databases from inception to September 2023, to identify studies measuring the aMAP score in patients for the ...
Mohamed E Haseeb, Ramez M Odat, Anas Elgenidy   +2 more
exaly   +5 more sources

The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study [PDF]

ImmunoTargets and Therapy
Li Chen,1,2,* Qiang Liu,2,* Chunlei Tan,3,* Tiangen Wu,4,* Meng Wu,5 Xiaosheng Tan,5 Jinwen Liu,1 Jing Wang2 1Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,
Chen L, Liu Q, Tan C, Wu T, Wu M, Tan X, Liu J, Wang J   +7 more
doaj   +4 more sources

[Application of aMAP score to assess the risk of hepatocarciongenesis in population of chronic liver disease in primary hospitals]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2021
Objective: The aMAP score is a hepatocellular carcinoma (HCC) risk prediction model based on an international cooperative cohort, which can be applied to various liver diseases. The aim of this study is to use the aMAP score to stratify the risk of HCC in patients with chronic liver disease (combined or non-combined metabolic diseases) admitted to ...
Li XH, Hao X, Deng YH, Liu XQ, Liu HY, Zhou FY, Fan R, Guo YB, Hou JL.   +8 more
europepmc   +3 more sources